Prevalence of Confirmed Penicillin Allergy Among Individuals Labeled as Allergic to Penicillin

Read full text Summarise with VIRAT
Authors: Fernando de Sá Del Fiol, BIANCA GIANOLA BELLINE SILVA, Beatriz Birelli do Nascimento, Leandro Aparecido de Souza, Jessica Cristina Bilizario Nogueirol
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This project investigates the frequency with which a penicillin allergy label corresponds to a confirmed penicillin allergy after formal diagnostic evaluation. Penicillin allergy is one of the most commonly reported drug allergies worldwide; however, growing evidence suggests that most individuals carrying this label are not truly allergic when assessed through validated diagnostic approaches such as skin testing and/or oral challenge. Mislabeling can lead to the unnecessary avoidance of beta-lactam antibiotics, use of broader-spectrum or less appropriate alternatives, increased healthcare costs, longer hospital stays, and worse clinical outcomes. The aim of this study is to estimate the prevalence of confirmed penicillin allergy among individuals previously labeled as allergic to penicillin and to explore variation across clinical settings and diagnostic strategies. The review includes studies evaluating patients with a reported penicillin allergy who underwent diagnostic assessment for confirmation or exclusion of true allergy. Data will be extracted on study characteristics, patient population, diagnostic methods, and the proportion of confirmed allergy cases. By synthesizing the available evidence, this project seeks to provide a clearer estimate of the true burden of confirmed penicillin allergy among labeled patients and to support clinical and antimicrobial stewardship strategies aimed at penicillin allergy delabeling when appropriate.

Fields of Study & Subjects

Drug-Induced Adverse Reactions Pharmacovigilance and Adverse Drug Reactions Contact Dermatitis and Allergies

Publication details

Publication date
28 March 2026
Language
EN
Document type
Preprint